Glenmark Pharmaceuticals Gets US FDA Nod for Fluticasone Propionate Inhalation Aerosol
Glenmark Pharmaceuticals Gets US FDA Nod for Fluticasone Propionate Inhalation Aerosol is drawing significant interest across the industry.
Glenmark Specialty, a unit of Glenmark Pharmaceuticals , received final approval from the US Food and Drug Administration for its fluticasone propionate inhalation aerosol, according to a...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Trump's SEC gave companies more power over investors. Lawsuits pushed them back
- Israel-Iran Tensions Disrupt Flights, Passengers Stranded in India
- 'O'Romeo' box office collection Day 13: Shahid Kapoor and Triptii Dimri starrer goes BEYOND Rs 94 crore worldwide
- New Court Complex Breaks Ground in Tirupati
Source: Original →